The partnership between is expected to improve access and help overcome gaps in care for consumers.
CVS did it with Caremark, Rite Aid did it with Envision, and now it’s Walgreens’ turn. The partnership between Walgreens Boots Alliance and OptumRx (the pharmacy benefit management wing of UnitedHealth) is expected to improve access to drugs for consumers.
According to an announcement by the UnitedHealth group, the integration will allow:
“We are excited to be working with Walgreens to create a new pharmacy solution that provides convenience and cost savings, and goes beyond filling prescriptions to deliver a more valuable pharmacy and health management experience for consumers,” said Larry Renfro, chief executive officer of Optum, in a statement.
Analysts predict that this partnership will help boost drug sales for Walgreens. However, some members with drug coverage from Optum might end up having to fill-in their prescriptions only at a Walgreens pharmacy, depending on the contract signed by their employers or drug benefits plan.
Both Walgreens and OptumRx expect that this partnership would have a significant impact on patient adherence and closing the gaps in care. “The deal will give pharmacists more access to information that will help them counsel patients who are on multiple drugs, aren’t getting refills, or taking pills that shouldn’t be taken together,” said Mark Thierer, chief executive officer of OptumRx.
The integrated pharmacy care will be available to commercial clients at the beginning of 2017.
Review Emphasizes Potential Infection Risks With BTK Inhibitors
November 2nd 2024Although Bruton tyrosine kinase (BTK) inhibitor monotherapy in chronic lymphocytic leukemia (CLL) has been a game-changer, patients have significantly increased risks of infection, especially in the upper respiratory tract.
Read More
Sustaining Compassionate Trauma Care Across Communities
September 30th 2024September is National Recovery Month, and we are bringing you another limited-edition month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In our final episode, we speak with Lyndra Bills, MD, and Shari Hutchison, MS.
Listen
PAH Treatment Outcomes Similar Regardless of Diagnosis Time
November 1st 2024The study findings underscore the importance of early initiation of macitentan and tadalafil among patients who have pulmonary arterial hypertension (PAH), and represent a shift in understanding of prognosis based on diagnosis timing.
Read More